The DOI matches its Crossref record; 336 of the 336 references it cites were found in a registry or an index.
Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse
Open accessAbstract
Alcoholism is a chronic relapsing disorder. Major characteristics observed in alcoholics during an initial period of alcohol abstinence are altered physiological functions and a negative emotional state. Evidence suggests that a persistent, cumulative adaptation involving a kindling/allostasis-like process occurs during the course of repeated chronic alcohol exposures that is critical for the negative symptoms observed during alcohol withdrawal. Basic studies have provided evidence for specific neurotransmitters within identified brain sites being responsible for the negative emotion induced by the persistent cumulative adaptation following intermittent-alcohol exposures. After an extended period of abstinence, the cumulative alcohol adaptation increases susceptibility to stress- and alcohol cue-induced negative symptoms and alcohol seeking, both of which can facilitate excessive ingestion of alcohol. In the alcoholic, stressful imagery and alcohol cues alter physiological responses, enhance negative emotion, and induce craving. Brain fMRI imaging following stress and alcohol cues has documented neural changes in specific brain regions of alcoholics not observed in social drinkers. Such altered activity in brain of abstinent alcoholics to stress and alcohol cues is consistent with a continuing ethanol adaptation being responsible. Therapies in alcoholics found to block responses to stress and alcohol cues would presumably be potential treatments by which susceptibility for continued alcohol abuse can be reduced. By continuing to define the neurobiological basis of the sustained alcohol adaptation critical for the increased susceptibility of alcoholics to stress and alcohol cues that facilitate craving, a new era is expected to evolve in which the high rate of relapse in alcoholism is minimized. 250
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 3×
“Previous reports have supported CRF being a primary central mediator of stress (Bale and Vale, 2004; Dunn and Berridge, 1990; Imaki et al., 1993; Koob and Heinrichs, 1999; Vale et al., 1981).”
BackgroundVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
The Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,566
The concept of allostasis in biology and biomedicine
McEwen, B. S., & Wingfield, J. C. (2003) · Hormones and Behavior · doi:10.1016/s0018-506x(02)00024-7 · Cited by 3,302 · cited 1×
“Allostasis, as a term, is stated to be an adaptive process of achieving functional stability by a physiological adjustment outside of normal homeostasis (McEwen, 2000; McEwen and Wingfield, 2003).”
BackgroundBardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,219
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Cited by
Stress and the HPA axis: role of glucocorticoids in alcohol dependence
Stephens, M. (2012) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v34.4.11 · Cited by 571
Hwa, L. S., Chu, A., Levinson, S. A., Kayyali, T. M., DeBold, J. F., & Miczek, K. A. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01545.x · Cited by 361
Alcohol dependence as a chronic pain disorder
Egli, M., Koob, G. F., & Edwards, S. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.010 · Cited by 347
Mindfulness-Based Relapse Prevention for substance craving
Witkiewitz, K., Bowen, S., Douglas, H., & Hsu, S. H. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.04.001 · Cited by 337
Seif, T., Chang, S.-J., Simms, J. A., Gibb, S. L., Dadgar, J., Chen, B. T., Harvey, B. K., Ron, D., Messing, R. O., Bonci, A., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3445 · Cited by 313
Disrupted Ventromedial Prefrontal Function, Alcohol Craving, and Subsequent Relapse Risk
Seo, D., Lacadie, C. M., Tuit, K., Hong, K.-I., Constable, R. T., & Sinha, R. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.762 · Cited by 301
Self-citationAlcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders
Blaine, S. K., & Sinha, R. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.037 · Cited by 257
“Through repeated cycles of binge consumption and withdrawal, there are significant increases in neuroendocrine tolerance and basal state autonomic upregulation (Breese et al., 2011; Sinha et al., 2011a,b).”
InfluentialCortical and subcortical gray matter shrinkage in alcohol-use disorders: a voxel-based meta-analysis
Yang, X., Tian, F., Zhang, H., Zeng, J., Chen, T., Wang, S., Jia, Z., & Gong, Q. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.034 · Cited by 257
Corticotropin releasing factor: A key role in the neurobiology of addiction
Zorrilla, E. P., Logrip, M. L., & Koob, G. F. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.01.001 · Cited by 254
Witkiewitz, K., Lustyk, M. K. B., & Bowen, S. (2013) · Psychology of Addictive Behaviors · doi:10.1037/a0029258 · Cited by 207
Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems
George, O., Le Moal, M., & Koob, G. F. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.11.004 · Cited by 184
Fox, H. C., D'Sa, C., Kimmerling, A., Siedlarz, K. M., Tuit, K. L., Stowe, R., & Sinha, R. (2012) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1251 · Cited by 150
Self-citationOswald, L. M., Wand, G. S., Kuwabara, H., Wong, D. F., Zhu, S., & Brasic, J. R. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3407-z · Cited by 114
“…observational studies has shown that stress may contribute to the pathogenesis and progression of substance use disorders (Back et al. 2010; Breese et al. 2011; Erb et al. 1996; Karlsgodt et al. 2003; Kreek et al. 2005; Laudet et al. 2004; Lu et al. 2003; Sinha 2001; Soderpalm and de Wit…”
Fox, H. C., Seo, D., Tuit, K., Hansen, J., Kimmerling, A., Morgan, P. T., & Sinha, R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111430746 · Cited by 112
“…recent studies have shown that subjective, bio-physiological and behavioral/bodily indicators of arousal and anxiety are both robustly associated with the negative reinforcing effects of cocaine and alcohol (Bergquist et al., 2010; Breese et al., 2011; Chaplin et al., 2010; Fox and Sinha, 2009).”
BackgroundSelf-citationCippitelli, A., Damadzic, R., Singley, E., Thorsell, A., Ciccocioppo, R., Eskay, R. L., & Heilig, M. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.10.016 · Cited by 84
Self-citationAlcohol stress response dampening: selective reduction of anxiety in the face of uncertain threat
Hefner, K. R., & Curtin, J. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111416691 · Cited by 74
“…implicate neuroadaptation in the stress response as a critical mechanism in addiction etiology across addictive drugs including alcohol, benzodiazepines, opiates, cocaine, nicotine, and marijuana (Breese et al., 2011; Koob and LeMoal, 2008; Shaham and Hope, 2005; Sinha, 2008; Weiss et al., 2001).”
Somkuwar, S. S., Vendruscolo, L. F., Fannon, M. J., Schmeichel, B. E., Nguyen, T. B., Guevara, J., Sidhu, H., Contet, C., Zorrilla, E. P., & Mandyam, C. D. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.06.006 · Cited by 64
Knapp, D. J., Whitman, B. A., Wills, T. A., Angel, R. A., Overstreet, D. H., Criswell, H. E., Ming, Z., & Breese, G. R. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.02.018 · Cited by 60
Self-citationJimenez, V. A., Herman, M. A., Cuzon Carlson, V. C., Walter, N. A., Grant, K. A., & Roberto, M. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0290-7 · Cited by 29
The use of sobriety nutritional therapy in the treatment of opioid addiction
Cunningham, P. M. (2016) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.1000282 · Cited by 13
“Chronic use alters brain functioning by a wear and tear process often resulting in negative behavioural responses until the substance is ingested, obtaining a temporary balance [19].”
BackgroundAbdoli, N., Farnia, V., Salemi, S., Tatari, F., Juibari, T. A., Alikhani, M., & Basanj, B. (2019) · Journal of Substance Use · doi:10.1080/14659891.2018.1549279 · Cited by 10
Metadata
- Authors
- Breese, G. R., Sinha, R., & Heilig, M.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 129
- Issue
- 2
- Pages
- 149-171
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2051283142
- Cited by
- 261
- References
- 336
- FWCI
- 10.48
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.